Cart
sales@molnova.com
NSC 3852
CAS No. 3565-26-2
NSC 3852 ( —— )
Catalog No. M20951 CAS No. 3565-26-2
NSC 3852 is a potent inhibitor of histone deacetylase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 46 | Get Quote |
|
| 50MG | 75 | Get Quote |
|
| 100MG | 113 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC 3852
-
NoteResearch use only not for human use.
-
Brief DescriptionNSC 3852 is a potent inhibitor of histone deacetylase.
-
DescriptionNSC 3852 is a potent inhibitor of histone deacetylase.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3565-26-2
-
Formula Weight174.16
-
Molecular FormulaC9H6N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=Nc1ccc(O)c2ncccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jeannine S. Strobl Christopher W. Seibert Yunbo Li Rana Nagarkatti Sheila M. Mitchell Alexa C. Rosypal Dharmendar Rathore and David S. Lindsay. Inhibition of Toxoplasma gondii and Plasmodium falciparum Infections in Vitro by NSC3852 a Redox Active Antiproliferative and Tumor Cell Differentiation Agent[J]. Journal of Parasitology 2009 95(1):p.215-223.
molnova catalog
related products
-
Givinostat
Givinostat or gavinostat, aslo known as ITF2357, is a potent and orally active histone deacetylase inhibitor with potential anti-inflammatory, anti-angiogenic, and antineoplastic activities.
-
KA2507
KA2507 is a potent and selective HDAC6 inibitor with an IC50 of 2.5nM.
-
Belinostat
Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.
